Friday, July 30, 2021
Home Breaking News Hero Technologies Receives Independent Valuation and Purchase Price Allocation for Veteran Hemp...

Hero Technologies Receives Independent Valuation and Purchase Price Allocation for Veteran Hemp Co. Acquisition

Fair value of November 2020 acquisition confirmed at $169,711

DOVER, DE / ACCESSWIRE / April 12, 2021 / Hero Technologies (OTC PINK:HENC) (Twitter: @heroicmindtech), a cannabis company focused on a vertically integrated strategy, today announced that it has received an independent third-party valuation and purchase price allocation for its acquisition of the assets of V Broker LLC dba Veteran Hemp Co.

Founded by U.S. military veterans, Veteran Hemp Co. is a Colorado-based online retailer and wholesaler of hemp and cannabinoid products. Hero Technologies acquired Veteran Hemp Co. in November 2020. The acquired assets are valued at $169,711.

The acquisition improved Hero Technologies’ balance sheet with $140,805 in total tangible assets, $71,526 in net tangible assets, and $98,195 in intangible assets, including trade names, customer base, and Goodwill.

The valuation and purchase price allocation were calculated by Doty Scott Enterprises, a well-respected provider of financial and business advisory services, including corporate valuations.

“We are pleased that an independent review has confirmed the fair value of our Veteran Hemp Co. asset acquisition,” said Hero Technologies’ CEO Gina Serkasevich. “As we continue to develop and execute our integrated ‘seed to sale’ market strategy for cannabis products, we strive to make wise investment decisions. Our carefully considered purchase of Veteran Hemp Co. benefits our balance sheet, our market reach-both retail and wholesale-and our shareholders.”

About Hero Technologies Inc.

Hero Technologies Inc. is a cannabis company working toward a vertically-integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (MSO).

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements may include: management plans relating to the proposed project; the expected timing of the completion of the proposed project; the ability to complete the proposed project; any statements of the plans and objectives of management for future operations, products or services, including the execution of plans proposed project; any statements of expectation or belief; projections related to certain financial metrics; and any statements of assumptions underlying any of the foregoing. Forward-looking statements are typically identified by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would” and other similar words and expressions or negatives of these words. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time and are beyond our control. Forward-looking statements speak only as of the date they are made. Neither Hero Technologies Inc. nor its holding company or subsidiaries assumes any duty and does not undertake to update any forward-looking statements. Because forward-looking statements, by their nature, are uncertain or assumptive to varying degrees, actual results or future events could differ, possibly materially, from those that Hero Technologies Inc., its holding company or subsidiaries anticipated in the forward-looking statements, and future results could differ materially from historical performance.

Hero Technologies Contact:

Ms. Gina Serkasevich, CEO
(302) 538-4165 | info@herotechnologiesinc.com

Brokers and Analysts:
Chesapeake Group
(410) 825-3930 | info@chesapeakegp.com

SOURCE: Hero Technologies Inc.

View source version on accesswire.com:
https://www.accesswire.com/639872/Hero-Technologies-Receives-Independent-Valuation-and-Purchase-Price-Allocation-for-Veteran-Hemp-Co-Acquisition


Disclaimer

This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of Hero Technologies Inc. (HENC) and does not buy, sell, or trade any shares of (HENC). This article does not provide a professional analysis of a (HENC) financial position. (HENC) financial position and all other information regarding the featured Company should be verified directly with (HENC). Please read our full disclaimer for more detailed information.

Most Popular

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient Centric...

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording &...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording...

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief...

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs

Advertisement

Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts
Loading